Dry Eye Disease Market Clinical Analysis, Growth, Research Outlook and Forecast – 2026| Horus Pharma, Johnson & Johnson, AbbVie Inc, Alcon Inc.

The “Global Dry Eye Disease Market” Research Report 2021-2026 is an in-depth study of the market, along with an analysis of its key segments. The relationship is built through extensive primary and secondary research. In-depth market data is generated through interviews and data collection from industry experts and professionals. The study is a detailed document on key aspects of the markets including trends, segmentation, growth prospects, opportunities, challenges, and competitive analysis.

The Dry Eye Disease Market is expected to register a CAGR of nearly 5.6% over the forecast period, with estimated market size of USD 4,998 million in 2020 and expected to reach 6,960 million by 2026.

Click the link to get a free Sample Copy of the Report: (Flat 25%)

https://www.marketinsightsreports.com/reports/05202907445/dry-eye-disease-market-growth-trends-covid-19-impact-and-forecasts-2021-2026/inquiry?Source=MS&Mode=28    

The research report is a compilation of key data with regards to the competitive landscape of this vertical and the multiple regions where the business has successfully established its position.

Top Companies in the Global Dry Eye Disease Market: AbbVie Inc (Allergan Plc), AFT Pharmaceuticals, Akorn, Alcon Inc., Bausch Health Companies Inc, ENTOD Research Cell UK Ltd, Horus Pharma, Johnson & Johnson, MiBo Medical Group, Otsuka Pharmaceutical Co. Ltd, Novaliq GmbH, and Other.

Key Market Trends:

Corticosteroid Drugs Segment is Expected to Hold a Major Market Share Over the Forecast Period

The lockdown measures in 2020 due to COVID-19, across the world, resulted in decreased public mobility and impacted the therapeutic industry significantly, as the rate of treatment that is non-immediate was being postponed to decrease the burden on healthcare infrastructure.?

Corticosteroids are effective anti-inflammatory drugs. These drugs are highly useful in short-term efficacy, and thus, are prescribed mostly for acute cases of dry eye diseases. Two of the major companies established in this segment are Bausch Health and AbbVie Inc (Allergan Plc). Often, these companies, as well as doctors, recommend corticosteroids, along with antibiotic therapy.

It has also been found that as the number of the elderly population is expected to grow in coming years who are more prone to eye-related disorders will ultimately drive the market in the future. Rising product approvals and new product launches are some of the other factors anticipated to propel the market for corticosteroids. For instance, in 2020, the FDA had approved loteprednol etabonate ophthalmic suspension 0.25% for short-term treatment of the signs and symptoms of dry eye disease.

Overall, this segment has the largest share under anti-inflammatory drugs in the market studied and is expected to register a steady CAGR over the forecast period.

Regional Analysis:

North America is Expected to Hold a Significant Share in the Market Over the Forecast Period

Governments and institutions are likely to take advantage of their advanced technologies during this period to turn the challenges brought by COVID-19 into opportunities. Ophthalmic consultation largely through smartphones has become a lifeline for consultation. For follow up on eye disorders, doctors are using images via electronic media. For poor patients in remote rural areas with no phone, this follow up was not possible. In remote areas, rural medicine supply for dry eye disorder patients has dried up.

On March 30, 2020, the US Centers for Medicare & Medicaid Services released temporary regulatory waivers and issued new rules for virtual visits using online applications for billable ophthalmic telemedical services. Such low-technology solutions may be one mechanism to assist with decompressing an office schedule in the post-COVID era. Thus, the patient opting for ophthalmic telemedical service is increasing, which has a positive impact on the market studied.

Geographically, North America holds a major share. As per the Government of Canada Statistics report 2019, in 2019 Canadian older population included 6,592,611 which accounted for 17.5% of the Canadian population. Although the proportion of seniors in Canada has been increasing over time.

Ask for TOC and Report Description:

https://www.marketinsightsreports.com/reports/05202907445/dry-eye-disease-market-growth-trends-covid-19-impact-and-forecasts-2021-2026?Source=MS&Mode=28   

What are the market factors that are explained in the report?

-Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a Global and regional scale.

-Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

–Analytical Tools: The Global Dry Eye Disease Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

The research includes historic data from 2015 to 2021 and forecasts until 2026 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Market Insights Reports
4893, Pepper drive, Harrisburg ,NC 28075,United States

Irfan Tamboli (Head of Sales)
Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com

We also offer customization on reports based on specific client requirements:
1- Free country level analysis for any 5 countries of your choice.
2- Free competitive analysis of any 5 key market players.
3- Free 40 analyst hours to cover any other data points

This release was published on openPR.